Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Elcin Barker Ergun
Person

Elcin Barker Ergun

Tracked across 2 events · 41 articles · First seen May 25, 2026 · Last active Jun 14, 2026

Sentiment
30
Attention
7
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
7 60
Tech
ASCO 2026 Oncology Research Presentations
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 29 to June 2, served as a crucial platform for major pharmaceutical and biotechnology companies to present significant advancements in…
Impact: Elcin Barker Ergun, CEO of the Menarini Group, emphasized the company's dedication to tackling difficult-to-treat cancers and accelerating innovation in targeted therapies.
May 25, 2026 · 33 articles
4 0
Tech
SENTRY Trial Data Myelofibrosis Treatment
Impact: Elcin Barker Ergun, CEO of Menarini Group, expressed optimism about the SENTRY study results and the potential for a new treatment option.
Jun 14, 2026 · 8 articles
Key Actions (1)
20 Elcin Barker Ergun commented on dataASCO 2026 Oncology...
NEWSDESK
Track Elcin Barker Ergun live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.